Harvest Integrated Research Organization (HiRO), a boutique global CRO, has signed an Memorandum of Understanding (MoU) with Hallym University Sacred Heart Hospital in Seoul, South Korea. This strategic alliance aims to drive innovation in drug research and development while strengthening collaboration across the medical and research sectors.
The collaboration outlines shared objectives focused on fostering innovation in health and health technology, accelerating drug research and development, and enhancing the efficiency of clinical trials, all while upholding the highest standards of quality and care. By uniting efforts, HiRO and Hallym University Sacred Heart Hospital are well-positioned to make significant progress in improving healthcare outcomes and addressing unmet clinical needs for patients in South Korea and beyond.
Dr Karen Chu, Founder and CEO of HiRO, remarked, "Hallym University Sacred Heart Hospital's robust clinical trial capabilities, combined with HiRO's extensive experience and our global leadership team's expertise, averaging 20 years in the field, will streamline workflows and accelerate timelines, ensuring the effective delivery of pioneering treatments to the market. This partnership not only seeks to drive innovation but also to cultivate international collaborations that will lead to meaningful advancements in medical research on a global scale.
Prof. Hyung-soo Kim, Director of Hallym University Sacred Heart Hospital added, "This agreement symbolises a remarkable opportunity to provide patients with more innovative treatment options. By integrating our clinical research capabilities with HiRO's global network, we aim to create a transformative collaboration model that bridges medical practice, research, and industry."
Through this agreement, both HiRO and Hallym University Sacred Heart Hospital are set to establish a partnership that strives for mutual success in clinical research and delivering more effective treatments, consequently enhancing health outcomes for patients both locally and globally.
